In the world of small molecule drug substance development and manufacturing, success is rarely determined by chemistry alone. Complex synthetic routes, aggressive development timelines, evolving regulatory expectations, and global supply chain constraints often converge within a single project. In this environment, robust project management is not merely a support function but an essential element of reliable CDMO execution.

At Yuhan CDMO, project management is embedded into the way we operate. Rather than relying on a single centralized role, our project management framework is built on close, cross‑functional collaboration across the three functional groups: Overseas Business, R&D, and Yuhan Chemical (cGMP Manufacturing). Dedicated project managers within each function work together as one integrated team, ensuring that every project moves forward with clear direction, defined accountability, and the speed required to meet today’s development challenges.

At Yuhan CDMO, project management is not an administrative layer added on top of operations. It is a core execution capability that connects strategy, science, and manufacturing. By embedding project managers within Overseas Business, R&D, and Manufacturing, and enabling seamless collaboration across these functions, we ensure that every project benefits from both deep technical expertise and disciplined execution.

For small molecule drug substance programs, where complexity is the norm and timelines leave little room for error, this integrated project management approach delivers what matters most to our partners: predictability, transparency, and results you can rely on.